Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study

被引:3
作者
Koto, Yuta [1 ,6 ]
Narita, Aya [2 ]
Noto, Shinichi [3 ]
Okada, Masafumi [4 ]
Ono, Midori [5 ]
Baba, Terumi [5 ]
Sagara, Rieko [5 ]
Sakai, Norio [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Child Healthcare & Genet Sci Lab, Div Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Tottori Univ, Fac Med, Inst Neurol Sci, Div Child Neurol, 86 Nishi Cho, Yonago, Tottori 6838503, Japan
[3] Niigata Univ Hlth & Welf, Dept Radiol Technol, 1398 Shimami Cho,Kita Ku, Niigata, Niigata 9503198, Japan
[4] IQVIA Solut Japan KK, Real World Evidence Solut & HEOR, 4-10-18 Takanawa,Minato Ku, Tokyo 1080074, Japan
[5] Takeda Pharmaceut Co Ltd, Japan Med Off, 2-1-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038668, Japan
[6] Kansai Med Univ, Fac Nursing, Grad Sch Nursing, 2-2-2 Shinmachi, Hirakata, Osaka 5731004, Japan
关键词
Caregiver burden; Gaucher disease; Japan; Caregiver Impact Questionnaire; Neuronopathic Gaucher disease; Zarit Caregiver Burden Interview; QUALITY-OF-LIFE; RELIABILITY; CHILDREN;
D O I
10.1016/j.ymgmr.2023.100994
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Gaucher disease (GD), a rare lysosomal storage disorder, is associated with considerable patient and caregiver burden. We examined the applicability of existing caregiver questionnaires and assessed the level of burden in caregivers of patients with GD.Methods: This cross-sectional, non-interventional study was conducted in Japan. Caregivers of patients with confirmed GD (any type) were recruited (patient association group and referral) for pre-testing (May 2021) or the main survey (October-December 2021). Caregivers completed the Caregiver Impact Questionnaire (CIQ; 30 items) and Zarit Caregiver Burden Interview (ZBI; 22 items) on paper. Total CIQ and ZBI scores and subscores were determined overall and by GD type. Inter-item correlations and test-retest reliability (2 rounds, 2 weeks apart) were calculated. The relationship between caregiving duration and caregiver burden was also analyzed.Results: Nine caregivers (type 2 [GD2]: n = 6; type 3 [GD3]: n = 3) and 25 caregivers (type 1 [GD1]: n = 2; GD2: n = 17; GD3: n = 6) completed the pre-test and main survey, respectively. In the main survey, mean total CIQ score, all CIQ subscores (except emotional function), and total ZBI score were highest in caregivers of patients with GD2 compared with caregivers of patients with GD1/GD3. High test-retest reliability (Kappa >0.6) was observed for 15 CIQ items and 16 ZBI items. CIQ and ZBI scores appeared to be positively correlated with each other and negatively correlated with caregiving duration. Conclusions: The CIQ and ZBI are applicable, reliable measures to assess burden in caregivers of patients with GD in Japan. Caregiver burden was highest in caregivers of patients with GD2 and decreased with caregiving duration.
引用
收藏
页数:8
相关论文
共 31 条
[1]   Psychometrics of the Zarit Burden Interview in Caregivers of Patients With Heart Failure [J].
Al-Rawashdeh, Sami Y. ;
Lennie, Terry A. ;
Chung, Misook L. .
JOURNAL OF CARDIOVASCULAR NURSING, 2016, 31 (06) :E21-E28
[2]   Quality of life and psychological functioning of pediatric and young adult patients with Gaucher disease, type 1 [J].
Alioto, Andrea G. ;
Gomez, Rowena ;
Moses, James ;
Paternostro, Jennifer ;
Packman, Seymour ;
Packman, Wendy .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2020, 182 (05) :1130-1142
[3]   Reliability and validity of the Japanese version of the Zarit Caregiver Burden Interview [J].
Ari, Y ;
Kudo, K ;
Hosokawa, T ;
Washio, M ;
Miura, H ;
Hisamichi, S .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1997, 51 (05) :281-287
[4]   Being the Pillar for Children with Rare Diseases-A Systematic Review on Parental Quality of Life [J].
Boettcher, Johannes ;
Boettcher, Michael ;
Wiegand-Grefe, Silke ;
Zapf, Holger .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (09)
[5]   The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease [J].
Charrow, J ;
Andersson, HC ;
Kaplan, P ;
Kolodny, EH ;
Mistry, P ;
Pastores, G ;
Rosenbloom, BE ;
Scott, CR ;
Wappner, RS ;
Weinreb, NJ ;
Zimran, A .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2835-2843
[6]   Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease [J].
Dinur, Tama ;
Istaiti, Majdolen ;
Frydman, Dafna ;
Becker-Cohen, Michal ;
Szer, Jeff ;
Zimran, Ari ;
Revel-Vilk, Shoshana .
ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
[7]   Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials [J].
Elstein, Deborahy ;
Belmatoug, Nadia ;
Deegan, Patrick ;
Goker-Alpan, Ozlem ;
Hughes, Derralynn A. ;
Schwartz, Ida Vanessa D. ;
Weinreb, Neal ;
Bonner, Nicola ;
Panter, Charlotte ;
Fountain, Donna ;
Lenny, Andrew ;
Longworth, Louise ;
Miller, Rachael ;
Shah, Koonal ;
Schenk, Jorn ;
Sen, Rohini ;
Zimran, Ari .
ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
[8]  
Gaucher Registry for Development Innovation & Analysis of Neuronopathic disease, 2023, GARDIAN REG TYP 2 3
[9]   Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire [J].
Harrington, Magdalena ;
Hareendran, Asha ;
Skalicky, Anne ;
Wilson, Hilary ;
Clark, Marci ;
Mikl, Jaromir .
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019, 3 (01)
[10]  
Ida H., 2012, NIPPON RINSHO, V2nd, P465